🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where groups with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Content Elimination

According to the social media company, the platform has removed problematic material and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Research also found communities with up to nine thousand participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, positive testimonials and detailed guides for preparing or administering at home.

After minutes of entering one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.

Item Information and Pricing

Within these communities, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially significant health risks”.